Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05621863 · ClinicalTrials.gov registry record · NA
Fruit and Vegetable Biomarker Discovery
A NA study of Biomarkers, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 280
- Enrollment target
- 1
- Study location
NCT05621863: Recruiting NA study of Biomarkers, sponsored by University of California, Davis.
NCT05621863 is a NA study of Biomarkers that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 280 participants, below the 696-participant average among 5 other Biomarkers trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05621863, a NA study of Biomarkers, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to find a set of markers in the blood and/or urine that can be linked to consumption of specific fruits and vegetables. This will allow for better understanding of the link between diet and health-related outcomes. Furthermore, the results of this study will lead to the development of new methods to evaluate the nutritional status of individuals in both community and clinical settings. Food frequency questionnaires and diaries/recalls can be affected by intentional or unintentional misreporting, and thus can create errors in determining nutritional status. This study will lead to the development of an objective way to assess the consumption of specific fruits and vegetables by the general population.
Primary Outcome
Urine metabolites will be measured by ultra-performance liquid chromatography mass spectrometry (UPLC-MS) before and after consumption of no, low, or high doses of study fruits and vegetables. Change will be assessed by the appearance of and change in levels of dietary-derived metabolites, which are candidate dietary biomarkers.
Conditions Studied
Interventions
- OTHER Aim 1 Meal Challenge 1
- OTHER Aim 1 Meal Challenge 2
- OTHER Aim 1 Meal Challenge 3
- OTHER Aim 2 Typical American Diet
- OTHER Aim 2 Typical American Diet Plus Test Foods
Study Locations (1)
California
- USDA ARS Western Human Nutrition Research Center - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT05621863 shows while recruiting
NCT05621863 is an interventional study that assigns participants to a tested intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap, below the 696-participant average among 5 other Biomarkers trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Biomarkers appearing as the primary indexed condition, and to 5 interventions - of which Aim 1 Meal Challenge 1 is the first listed.
NCT05621863 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05621863 about?
NCT05621863 is a clinical study titled "Fruit and Vegetable Biomarker Discovery". The purpose of this research is to find a set of markers in the blood and/or urine that can be linked to consumption of specific fruits and vegetables. This will allow for better understanding of the link between diet and health-related outcomes. Furthermore, the results of this study will lead to t...
What is the current status of trial NCT05621863?
This trial is currently recruiting. It is a NA study. The enrollment target is 280 participants. The study started on 2023-04-01. Estimated completion is 2026-08-31.
What conditions does trial NCT05621863 study?
This clinical trial studies the following conditions: Biomarkers.
What interventions are being tested in trial NCT05621863?
The interventions under investigation include: Aim 1 Meal Challenge 1 (OTHER), Aim 1 Meal Challenge 2 (OTHER), Aim 1 Meal Challenge 3 (OTHER), Aim 2 Typical American Diet (OTHER), Aim 2 Typical American Diet Plus Test Foods (OTHER).
Who is sponsoring clinical trial NCT05621863?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05621863 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Biomarkers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
RECRUITING
-
Vanderbilt Memory and Aging Project
RECRUITING
-
Combining Biomarkers and Electronic Risk Scores to Predict AKI in Hospitalized Patients
RECRUITING
-
Molecular Assessment and Profiling of Liver Transplant Recipients
ACTIVE NOT RECRUITING
-
Scaling and Root Planing (SRP) With and Without Minocycline HCl Microspheres, 1 mg
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04084730 · 280 participants · Phase 2
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- NCT04518657 · 280 participants · NA
Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis
- NCT04634916 · 280 participants · NA
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- NCT04829617 · 280 participants · NA
Promoting Well-being and Health in Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI